A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.

I recently saw four patients in one morning who had atrial fibrillation and either one or two risk factors for stroke. None had symptoms warranting rhythm control or tachycardia requiring rate-control ...

Researchers conducted a meta-analysis of 31 studies (3 randomized controlled trials, 17 prospective cohort studies, and 11 retrospective studies) published through November 2025. The analysis included ...

DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...

The OPTION trial showed equivalence between Watchman FLX and oral anticoagulation in preventing stroke, systemic embolism, and all-cause death post-ablation. Subgroup analyses revealed consistent ...

Retrospective data support use of oral anticoagulants for death and MACE risk reduction in patients with end-stage kidney disease and nonvalvular atrial fibrillation who have an elevated CHA2DS2-VASc ...

Recent randomized evidence supports considering anticoagulation discontinuation after successful atrial fibrillation ablation, but only for carefully selected patients who remain arrhythmia-free and ...

Atrial fibrillation is the most common sustained cardiac arrhythmia, conferring an elevated risk of stroke and systemic embolism. Anticoagulation has long formed the cornerstone of stroke prevention, ...

Dear Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I've been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...